1. Home
  2. CLRB vs SOS Comparison

CLRB vs SOS Comparison

Compare CLRB & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • SOS
  • Stock Information
  • Founded
  • CLRB 2002
  • SOS 2004
  • Country
  • CLRB United States
  • SOS China
  • Employees
  • CLRB N/A
  • SOS N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • SOS Finance: Consumer Services
  • Sector
  • CLRB Health Care
  • SOS Finance
  • Exchange
  • CLRB Nasdaq
  • SOS Nasdaq
  • Market Cap
  • CLRB 12.5M
  • SOS 14.8M
  • IPO Year
  • CLRB N/A
  • SOS 2017
  • Fundamental
  • Price
  • CLRB $0.25
  • SOS $5.78
  • Analyst Decision
  • CLRB Hold
  • SOS
  • Analyst Count
  • CLRB 2
  • SOS 0
  • Target Price
  • CLRB N/A
  • SOS N/A
  • AVG Volume (30 Days)
  • CLRB 729.7K
  • SOS 21.6K
  • Earning Date
  • CLRB 05-13-2025
  • SOS 01-01-0001
  • Dividend Yield
  • CLRB N/A
  • SOS N/A
  • EPS Growth
  • CLRB N/A
  • SOS N/A
  • EPS
  • CLRB N/A
  • SOS N/A
  • Revenue
  • CLRB N/A
  • SOS $111,124,000.00
  • Revenue This Year
  • CLRB N/A
  • SOS N/A
  • Revenue Next Year
  • CLRB N/A
  • SOS N/A
  • P/E Ratio
  • CLRB N/A
  • SOS N/A
  • Revenue Growth
  • CLRB N/A
  • SOS N/A
  • 52 Week Low
  • CLRB $0.22
  • SOS $4.04
  • 52 Week High
  • CLRB $3.49
  • SOS $19.05
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 39.17
  • SOS 56.58
  • Support Level
  • CLRB $0.23
  • SOS $4.48
  • Resistance Level
  • CLRB $0.27
  • SOS $7.51
  • Average True Range (ATR)
  • CLRB 0.02
  • SOS 0.46
  • MACD
  • CLRB -0.00
  • SOS 0.17
  • Stochastic Oscillator
  • CLRB 15.12
  • SOS 38.94

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: